Basics Pfizer Inc. Pfizer Inc is a biopharmaceutical company that discovers, develops, manufactures, and markets healthcare products including medicines, and vaccines as well as many of the consumer healthcare products. IPO Date: January 2, 1990 Sector: Healthcare Industry: Pharma Market Cap: $140.38B Activated in VL: True Average Daily Range Avg Daily Range: $0.27 | 0.89% Avg Daily Range (30 D): $0.32 | 1.27% Avg Daily Range (90 D): $0.25 | 1.02% Institutional Daily Volume Avg Daily Volume: 30.55M Avg Daily Volume (30 D): 51.07M Avg Daily Volume (90 D): 40.63M Trade Size Avg Trade Size (Sh.): 310 Avg Trade Size (Sh.) (30 D): 268 Avg Trade Size (Sh.) (90 D): 276 Institutional Trades Total Inst.Trades: 364,078 Avg Inst. Trade: $3.48M Avg Inst. Trade (30 D): $3.45M Avg Inst. Trade (90 D): $4.06M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 65 Market Closing Trades Avg Closing Trade: $80.43M Avg Closing Trade (30 D): $106.9M Avg Closing Trade (90 D): $106.59M Avg Closing Volume: 2.51M     News Oct 22, 2025 @ 10:00 AM Nurix Initiates DAYBreakâ„¢ Pivotal Study of B... Source: Nurix Therapeutics, Inc. Oct 20, 2025 @ 1:00 PM Weight Loss Drugs Market Set to Reach USD 50.26 Bi... Source: Sns Insider Oct 18, 2025 @ 7:00 AM Nurix Therapeutics Reports New Clinical Data from ... Source: Nurix Therapeutics Oct 17, 2025 @ 4:43 PM UK Health Agency Recommends GSK-Backed ViiV Health... Source: Vandana Singh Oct 17, 2025 @ 3:23 PM QSM Asset Management Dumps 36,000 Whirlpool (WHR) ... Source: Howard Smith Financials   TTM Q2 2025 Q1 2025 Basic EPS $1.89 $.51 $.52 Diluted EPS $1.88 $.51 $.52 Revenue $ 63.83B $ 14.65B $ 13.72B Gross Profit $ 46.04B $ 10.88B $ 10.87B Net Income / Loss $ 10.79B $ 2.93B $ 2.97B Operating Income / Loss $ 10.53B $ 3.04B $ 2.79B Cost of Revenue $ 17.8B $ 3.78B $ 2.85B Net Cash Flow $ 574M $ 214M $ 375M PE Ratio 13.15